The First Narcolepsy Drug That Treats the Underlying Disease Is Approved but Not Yet Available to Patients

The First Narcolepsy Drug That Treats the Underlying Disease Is Approved but Not Yet Available to Patients

Orzeyful is approved for narcolepsy type 1, but DEA scheduling must finish first. Here is who qualifies and when it may reach pharmacies.

Institute Publishes Evidence Report on New Narcolepsy Treatment

An independent research institute evaluated the clinical effectiveness and value of oveporexton, an investigational orexin receptor 2 agonist for narcolepsy type 1. Key takeaways: The Institute for Clinical and Economic Review (ICER) released a final evidence report on oveporexton, an investigational therapy for narcolepsy type 1. The drug received a B+ evidence rating compared to no pharmacological treatment and a C++ rating compared to active…

FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug

WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Takeda Pharmaceuticals America’s Orzeyful tablets for adults with narcolepsy type 1, making it the first treatment cleared to address the …